| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


From the * Unidad de Investigacion Medica en
Genetica Humana, Hospital de Pediatria; and
Sección de Andrología, Hospital
de Especialidades, Centro Medico Nacional Siglo XXI-IMSS, Mexico, D.F.,
Mexico.
| Correspondence to: Haydee Rosas-Vargas, Unidad de Investigacion Medica en Genetica Humana, Hospital de Pediatria, Centro Medico Nacional Siglo XXI-IMSS, Av Cuauhtemoc No 330, Col Doctores, Delegacion Cuauhtemoc. 06725 Mexico, D.F., Mexico (e-mail: hayrov{at}hotmail.com). |
2 = 4.42; P = .03) and genotypic frequencies
(
2 = 3.96; P = .04) between patients and controls for the 894
G/T eNOS polymorphism. Presence of the 894T allele in carriers increased the
risk of ED (odds ratio [TT + GT versus GG] = 2.37; 95% confidence interval,
1.08 to 5.21; P = .02). Multiple logistic regression analysis showed that the
Glu298Asp polymorphism was an independent factor for ED, as was diabetes
mellitus, hypertension, cardiac disease, and cigarette smoking. No association
was found between ACE I/D polymorphism and ED in the population studied.
Therefore, our results suggest that Glu298Asp eNOS polymorphism plays a role
as a genetic susceptibility factor for ED.
Key words: Angiotensin-converting enzyme, endothelial dysfunction, impotence
This article has been cited by other articles:
![]() |
C. S. Saigal, H. Wessells, J. Pace, M. Schonlau, T. J. Wilt, and for the Urologic Diseases in America Project Predictors and Prevalence of Erectile Dysfunction in a Racially Diverse Population Arch Intern Med, January 23, 2006; 166(2): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |